U.S. Vice President Mike Pence promised that Americans would have access in the days ahead to more than 2,000 laboratories capable of processing coronavirus tests, and a leading expert said the country would launch a new phase of testing for the fast-spreading disease.
Gilead Sciences Inc. started two late-stage studies to test the company’s drug in patients with severe and moderate cases of the illness caused by the coronavirus, sending the drug firm’s shares up.
Med Ad News spoke with Christian Heidbreder, Ph.D., Chief Scientific Officer of Indivior Inc., about some of the barriers to patients seeking treatment for opioid use disorder, how to integrate treatment for opioid use disorder and infectious disease services, and the company’s efforts to provide treatments for those struggling with the disorder.
The World Health Organization (WHO) gave the coronavirus that began in Wuhan, China, an official name: COVID-19. The most recent figures indicate there are more than 45,000 infections worldwide and the virus has killed more than 1,100 people.
The National Institutes of Health (NIH) ceased administration of an investigational HIV vaccine after interim data revealed that the treatment was not working in preventing the virus.